Copyright
©The Author(s) 2025.
World J Diabetes. Mar 15, 2025; 16(3): 92003
Published online Mar 15, 2025. doi: 10.4239/wjd.v16.i3.92003
Published online Mar 15, 2025. doi: 10.4239/wjd.v16.i3.92003
Figure 5 lnc-MGC affects the progression of diabetic retinopathy through miR-495-3p.
A: Transfection efficiency was detected by RT-qPCR; B: Cell proliferation was detected by CCK-8 assay; C: Cell apoptosis was detected by TUNEL assay. The scale bar represents 100 μm; D: The expression of the inflammatory cytokines TNF-α, IL-1β, IL-6 was detected by ELISA; E: reactive oxygen species were detected by flow cytometry; F-H: Western blotting was used to detect the expression of related proteins. aP < 0.05, bP < 0.01, and cP < 0.001. Inhibitor: MiR-495-3p inhibitor; NC: Normal control; HG: High glucose; ROS: Reactive oxygen species.
- Citation: Luo YY, Ba XY, Wang L, Zhang YP, Xu H, Chen PQ, Zhang LB, Han J, Luo H. LEF1 influences diabetic retinopathy and retinal pigment epithelial cell ferroptosis via the miR-495-3p/GRP78 axis through lnc-MGC. World J Diabetes 2025; 16(3): 92003
- URL: https://www.wjgnet.com/1948-9358/full/v16/i3/92003.htm
- DOI: https://dx.doi.org/10.4239/wjd.v16.i3.92003